However, in tumors such as lung cancer, miR-126 can inhibit tumor angiogenesis by lowering VEGFA levels and activating signaling pathways such as Akt/mTOR/Erk1/2, ultimately suppressing tumor growth [23]. The gene discussed is MAPK3; the disease is neoplasm.